SARS-CoV-2-NP3 Primary Antibody

Item Information
Catalog #
Size
Price
Description

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target.

Product Overview
Entrez GenelD
43740575
Clone#
6G7A3
Host / Isotype
Mouse / Mouse IgG1
Immunogen
Purified recombinant fragment of SARS-CoV-2-N (AA: 240-419) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
4°C; -20°C for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
ELISA
1/10000
References
1,Nature. 2020 Apr 30. doi: 10.1038/s41586-020-2286-9. Online ahead of print;2,Nature. 2020 Mar;579(7798):265-269.
Product Image
ELISA
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)
WESTERN BLOT
Figure 2: Western blot analysis using SARS-CoV-2-NP3 mAb against human SARS-CoV-2-N (AA: 240-419) recombinant protein. lane 1 :(100 ng); lane 2 :(50 ng); lane 3 :(25 ng); lane 4 :(10 ng); lane 5 :(2.5 ng); (Expected MW is 23.7 kDa)
Figure 2: Western blot analysis using SARS-CoV-2-NP3 mAb against human SARS-CoV-2-N (AA: 240-419) recombinant protein. lane 1 :(100 ng); lane 2 :(50 ng); lane 3 :(25 ng); lane 4 :(10 ng); lane 5 :(2.5 ng); (Expected MW is 23.7 kDa)
WESTERN BLOT
Figure 2: Western blot analysis using SARS-CoV-2-NP3 mAb against human SARS-CoV-2-N (AA: 1-419) recombinant protein. lane 1 :(100 ng); lane 2 :(50 ng); lane 3 :(25 ng); lane 4 :(10 ng); lane 5 :(2.5 ng); (Expected MW is 49.2 kDa)
Figure 2: Western blot analysis using SARS-CoV-2-NP3 mAb against human SARS-CoV-2-N (AA: 1-419) recombinant protein. lane 1 :(100 ng); lane 2 :(50 ng); lane 3 :(25 ng); lane 4 :(10 ng); lane 5 :(2.5 ng); (Expected MW is 49.2 kDa)
For Research Use Only. Not for use in diagnostic procedures.